Economic data collection during efficacy trials will be discussed at HHS workshop.
Executive Summary
ECONOMIC DATA COLLECTION IN CONJUNCTION WITH EFFICACY TRIALS TO BE DISCUSSED at the Department of Health & Human Services cost-effectiveness workshop scheduled for Nov. 25-26 at the National Institutes of Health campus in Bethesda, Md. The workshop is organized around the Panel on Cost-Effectiveness in Health and Medicine report released earlier this year ("The Pink Sheet" Aug. 5, T&G-16). The report states that a "rigorously designed clinical trial" may be necessary for a cost-effectiveness analysis of "a pharmaceutical agent with the potential to create undesired side effects and for which small statistical biases in study data can lead to misleading results."